BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24405518)

  • 41. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit.
    Guidet B; Flaatten H; Boumendil A; Morandi A; Andersen FH; Artigas A; Bertolini G; Cecconi M; Christensen S; Faraldi L; Fjølner J; Jung C; Marsh B; Moreno R; Oeyen S; Öhman CA; Pinto BB; Soliman IW; Szczeklik W; Valentin A; Watson X; Zafeiridis T; De Lange DW;
    Intensive Care Med; 2018 Jul; 44(7):1027-1038. PubMed ID: 29774388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Foregoing life-sustaining treatment in an Israeli ICU.
    Eidelman LA; Jakobson DJ; Pizov R; Geber D; Leibovitz L; Sprung CL
    Intensive Care Med; 1998 Feb; 24(2):162-6. PubMed ID: 9539075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. End-of-life after birth: death and dying in a neonatal intensive care unit.
    Singh J; Lantos J; Meadow W
    Pediatrics; 2004 Dec; 114(6):1620-6. PubMed ID: 15574624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The frequency of withdrawal from acute care is impacted by severe acute renal failure.
    Swartz R; Perry E; Daley J
    J Palliat Med; 2004 Oct; 7(5):676-82. PubMed ID: 15588359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Limitation of life support: frequency and practice in a Hong Kong intensive care unit.
    Buckley TA; Joynt GM; Tan PY; Cheng CA; Yap FH
    Crit Care Med; 2004 Feb; 32(2):415-20. PubMed ID: 14758157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Withdrawing and withholding life-sustaining treatment.
    Cochrane TI
    Handb Clin Neurol; 2013; 118():147-53. PubMed ID: 24182374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Process of forgoing life-sustaining treatment in a university hospital: an empirical study.
    Faber-Langendoen K; Bartels DM
    Crit Care Med; 1992 May; 20(5):570-7. PubMed ID: 1374002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Withholding and withdrawing life-support therapy in an Emergency Department: prospective survey.
    Le Conte P; Baron D; Trewick D; Touzé MD; Longo C; Vial I; Yatim D; Potel G
    Intensive Care Med; 2004 Dec; 30(12):2216-21. PubMed ID: 15517162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hospital Policy Variation in Addressing Decisions to Withhold and Withdraw Life-Sustaining Treatment.
    Piscitello GM; Lyons PG; Koch VG; Parker WF; Huber MT
    Chest; 2024 Apr; 165(4):950-958. PubMed ID: 38184166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Forgoing life-sustaining treatments: comparison of attitudes between Israeli and North American intensive care healthcare professionals.
    Soudry E; Sprung CL; Levin PD; Grunfeld GB; Einav S
    Isr Med Assoc J; 2003 Nov; 5(11):770-4. PubMed ID: 14650099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Withdrawing care. Experience in a medical intensive care unit.
    Lee DK; Swinburne AJ; Fedullo AJ; Wahl GW
    JAMA; 1994 May; 271(17):1358-61. PubMed ID: 8158822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Withholding/withdrawal of life support in trauma patients: is there an age bias?
    Plaisier BR; Blostein PA; Hurt KJ; Malangoni MA
    Am Surg; 2002 Feb; 68(2):159-62. PubMed ID: 11842963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Withdrawal of active treatment in intensive care: what is stopped - comparison between belief and practice.
    Psirides AJ; Sturland S
    Crit Care Resusc; 2009 Sep; 11(3):210-4. PubMed ID: 19737124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Severe stroke: prognosis, intensive care admission and withhold and withdrawal treatment decisions].
    Crozier S; Santoli F; Outin H; Aegerter P; Ducrocq X; Bollaert PÉ
    Rev Neurol (Paris); 2011; 167(6-7):468-73. PubMed ID: 21565374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients' prognosis: a multicenter study of the Outcomerea Research Group.
    Lautrette A; Garrouste-Orgeas M; Bertrand PM; Goldgran-Toledano D; Jamali S; Laurent V; Argaud L; Schwebel C; Mourvillier B; Darmon M; Ruckly S; Dumenil AS; Lemiale V; Souweine B; Timsit JF;
    Intensive Care Med; 2015 Oct; 41(10):1763-72. PubMed ID: 26149302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decision making for the critically ill neonate near the end of life.
    Cook LA; Watchko JF
    J Perinatol; 1996; 16(2 Pt 1):133-6. PubMed ID: 8732563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors associated with life-sustaining treatment restriction in a general intensive care unit.
    Skjaker SA; Hoel H; Dahl V; Stavem K
    PLoS One; 2017; 12(7):e0181312. PubMed ID: 28719660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The possible impact of the German DRGs reimbursement system on end-of-life decision making in a surgical intensive care unit.
    Stachura P; Oberender P; Bundscherer AC; Wiese CH
    Wien Klin Wochenschr; 2015 Feb; 127(3-4):109-15. PubMed ID: 25622109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Withdrawing may be preferable to withholding.
    Vincent JL
    Crit Care; 2005 Jun; 9(3):226-9. PubMed ID: 15987405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment limitations at admission to intensive care units in Australia and New Zealand: prevalence, outcomes, and resource use*.
    Godfrey G; Pilcher D; Hilton A; Bailey M; Hodgson CL; Bellomo R
    Crit Care Med; 2012 Jul; 40(7):2082-9. PubMed ID: 22584761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.